Rutland Herald23h
UVM Extension: Liver fluke alert
Sheep and goat farmers in the Northeast have reported 20% losses from herds this winter due to liver fluke, a trematode or ...
Mom Breaks Tailbone on Ski Slopes, Learns Shocking News from Doctor: 'By the Way, You Have a Tumor' (Exclusive)
A collision on a ski slope led to Liz Healy being diagnosed with two rare cancers. Two months later, she underwent a 10-hour ...
Inside the Royal Free - what it tells us about the NHS
The BBC has been reporting live from the Royal Free Hospital in London to illustrate the pressures facing the health service ...
emjreviews.com4d
Diagnostic and Surgical Challenges in Extradigital Glomus Tumour: A Case Report
Glomus tumours are uncommon, benign neoplasms originating from the glomus body, predominantly affecting adults between 20–40 years of ...
Cure Today2d
Nubeqa Plus ADT Effective in mHSPC Regardless of Disease Volume
Nubeqa plus ADT improved rPFS in mHSPC regardless of disease volume, reducing the risk of radiological progression or death ...
Silent cancer that kills 70% of people in a year - three ways to check your risk
Tragically, it claims the lives of 9,558 people annually, with over 70% succumbing within a year of being diagnosed. Just one ...
AFP23h
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...
Guardant Health: Asymptomatic Screening Creating An Asymmetric Opportunity
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
The silent cancer that kills 70% of people within a year - the three questions to check your risk
Tragically, it claims the lives of 9,558 people annually, with over 70% succumbing within a year of being diagnosed. Just one ...
ahajournals.org5d
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects
Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...
Three questions to check your risk of silent cancer that kills 70% within a year
Sadly the disease will kill 9,558 people every year with just over 70% dying within 12 months of their diagnosis. One in 10 ...